India’s pharmaceutical export sector is set to benefit from a new cold-chain rail service launched between Hyderabad and Mumbai, a move expected to improve the transportation of temperature-sensitive medicines and strengthen the country’s expor...
Roche’s blood test breakthrough for early Alzheimer’s detection is drawing global attention after the company received the CE Mark approval in Europe for its Elecsys plasma pTau217 test. The new blood test to detect Alzheimer’s is expected...
Dr Reddy’s Laboratories is expanding its semaglutide generic franchise while trimming parts of its oncology pipeline as the company sharpens its focus on the fast-growing obesity treatment market and diabetes care segment.
Every year on May 12, the world celebrates International Nurses Day to recognize the extraordinary contribution of nurses in healthcare systems worldwide. The day marks the birth anniversary of Florence Nightingale, the founder of modern nursing...
Eli Lilly has halted its India obesity awareness campaign after facing regulatory scrutiny, putting the spotlight on how pharmaceutical companies promote obesity-related healthcare in the country. The U.S.-based drugmaker paused its campaig...
SwishX, a Bengaluru-based startup backed by $2.2M in seed funding, launches the world's first agentic AI platform to modernise pharma and medtech sales, marketing, and distribution across a $400 billion emerging market opportunity.
A new one-time cell therapy, for HIV infection has shown promising results in a small early-stage study, raising hopes for a future where people living with HIV may not need lifelong daily medication. Researchers found that the experiment...
Biocon, Health Canada approval, and antifungal injection developments received a major boost after Biocon Pharma Ltd secured approval for Micafungin for Injection, strengthening the company’s presence in regulated international pharmaceuti...
India’s pharmaceutical sector witnessed major regulatory changes between May 4 and May 9 as the Central Drugs Standard Control Organisation (CDSCO) rolled out stricter compliance measures and accelerated approval reforms.
Abbott has launched its TriClip TEER system in India, bringing a new minimally invasive treatment option for patients suffering from tricuspid regurgitation, a serious heart valve disorder caused by a leaking tricuspid valve.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")